175 related articles for article (PubMed ID: 38334679)
1. Green-Synthesized Silver and Selenium Nanoparticles Using Berberine: A Comparative Assessment of In Vitro Anticancer Potential on Human Hepatocellular Carcinoma Cell Line (HepG2).
Khaled AM; Othman MS; Obeidat ST; Aleid GM; Aboelnaga SM; Fehaid A; Hathout HMR; Bakkar AA; Moneim AEA; El-Garawani IM; Morsi DS
Cells; 2024 Feb; 13(3):. PubMed ID: 38334679
[TBL] [Abstract][Full Text] [Related]
2. Green-synthetized selenium nanoparticles using berberine as a promising anticancer agent.
Othman MS; Obeidat ST; Al-Bagawi AH; Fareid MA; Fehaid A; Abdel Moneim AE
J Integr Med; 2022 Jan; 20(1):65-72. PubMed ID: 34802980
[TBL] [Abstract][Full Text] [Related]
3. Silver Nanoparticles Exhibit the Dose-Dependent Anti-Proliferative Effect against Human Squamous Carcinoma Cells Attenuated in the Presence of Berberine.
Dziedzic A; Kubina R; Bułdak RJ; Skonieczna M; Cholewa K
Molecules; 2016 Mar; 21(3):365. PubMed ID: 26999092
[TBL] [Abstract][Full Text] [Related]
4. Antitumor Activity of Zinc Nanoparticles Synthesized with Berberine on Human Epithelial Colorectal Adenocarcinoma (Caco-2) Cells through Acting on Cox-2/NF-kB and p53 Pathways.
Othman MS; Al-Bagawi AH; Obeidat ST; Fareid MA; Habotta OA; Moneim AEA
Anticancer Agents Med Chem; 2022; 22(10):2002-2010. PubMed ID: 34607550
[TBL] [Abstract][Full Text] [Related]
5. Berberine-loaded albumin nanoparticles reverse aflatoxin B1-induced liver hyperplasia.
Khedr SM; Ghareeb DA; Fathy SA; Hamdy GM
BMC Pharmacol Toxicol; 2023 Aug; 24(1):42. PubMed ID: 37559065
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology applications for treatment of hepatic infections via modulating Hepatic histopathological and DNA alterations.
Gad SS; Abdelrahim DS; Ismail SH; Ibrahim SM
Bioorg Chem; 2022 Oct; 127():105927. PubMed ID: 35868104
[TBL] [Abstract][Full Text] [Related]
7. Selenium and silver nanoparticles: A new approach for treatment of bacterial and viral hepatic infections via modulating oxidative stress and DNA fragmentation.
Gad SS; Abdelrahim DS; Ismail SH; Ibrahim SM
J Biochem Mol Toxicol; 2022 Mar; 36(3):e22972. PubMed ID: 34964201
[TBL] [Abstract][Full Text] [Related]
8. Effect of silver nanoparticles in the induction of apoptosis on human hepatocellular carcinoma (HepG2) cell line.
Ahmadian E; Dizaj SM; Rahimpour E; Hasanzadeh A; Eftekhari A; Hosain Zadegan H; Halajzadeh J; Ahmadian H
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():465-471. PubMed ID: 30274079
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic and epigenetic effects of berberine-loaded chitosan/pectin nanoparticles on AGS gastric cancer cells: Role of the miR-185-5p/KLF7 axis, DNMTs, and global DNA methylation.
Babaeenezhad E; Rashidipour M; Jangravi Z; Moradi Sarabi M; Shahriary A
Int J Biol Macromol; 2024 Mar; 260(Pt 2):129618. PubMed ID: 38253156
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects.
El-Sheikh SMA; Khairy MH; Osama E; Metwally MMM; Galal AAA
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):631-643. PubMed ID: 33104848
[TBL] [Abstract][Full Text] [Related]
11. Green synthesis of selenium nanoparticles with extract of hawthorn fruit induced HepG2 cells apoptosis.
Cui D; Liang T; Sun L; Meng L; Yang C; Wang L; Liang T; Li Q
Pharm Biol; 2018 Dec; 56(1):528-534. PubMed ID: 30387372
[TBL] [Abstract][Full Text] [Related]
12. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
13. Shrimp shells extracted chitin in silver nanoparticle synthesis: Expanding its prophecy towards anticancer activity in human hepatocellular carcinoma HepG2 cells.
Vijayakumar M; Priya K; Ilavenil S; Janani B; Vedarethinam V; Ramesh T; Arasu MV; Al-Dhabi NA; Kim YO; Kim HJ
Int J Biol Macromol; 2020 Dec; 165(Pt A):1402-1409. PubMed ID: 33045301
[TBL] [Abstract][Full Text] [Related]
14. PEG-nanolized ultrasmall selenium nanoparticles overcome drug resistance in hepatocellular carcinoma HepG2 cells through induction of mitochondria dysfunction.
Zheng S; Li X; Zhang Y; Xie Q; Wong YS; Zheng W; Chen T
Int J Nanomedicine; 2012; 7():3939-49. PubMed ID: 22915845
[TBL] [Abstract][Full Text] [Related]
15. The cellular uptake of Cordyceps sinensis exopolysaccharide‑selenium nanoparticles and their induced apoptosis of HepG2 cells via mitochondria- and death receptor-mediated pathways.
Zhang X; Xiao Y; Huang Q
Int J Biol Macromol; 2023 Aug; 247():125747. PubMed ID: 37429344
[TBL] [Abstract][Full Text] [Related]
16. Induction of Apoptosis by Berberine in Hepatocellular Carcinoma HepG2 Cells via Downregulation of NF-κB.
Li M; Zhang M; Zhang ZL; Liu N; Han XY; Liu QC; Deng WJ; Liao CX
Oncol Res; 2017 Jan; 25(2):233-239. PubMed ID: 28277195
[TBL] [Abstract][Full Text] [Related]
17. Novel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitro.
Xia Y; You P; Xu F; Liu J; Xing F
Nanoscale Res Lett; 2015 Dec; 10(1):1051. PubMed ID: 26334544
[TBL] [Abstract][Full Text] [Related]
18. Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma.
Xia Y; Zhong J; Zhao M; Tang Y; Han N; Hua L; Xu T; Wang C; Zhu B
Drug Deliv; 2019 Dec; 26(1):1-11. PubMed ID: 31928356
[TBL] [Abstract][Full Text] [Related]
19. Berberine-loaded Janus nanocarriers for magnetic field-enhanced therapy against hepatocellular carcinoma.
Wang Z; Wang YS; Chang ZM; Li L; Zhang Y; Lu MM; Zheng X; Li M; Shao D; Li J; Chen L; Dong WF
Chem Biol Drug Des; 2017 Mar; 89(3):464-469. PubMed ID: 27618577
[TBL] [Abstract][Full Text] [Related]
20. Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis.
Al-Noshokaty TM; Mesbah NM; Abo-Elmatty DM; Abulsoud AI; Abdel-Hamed AR
Life Sci; 2022 Aug; 303():120675. PubMed ID: 35640776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
